Goldman Sachs Exchanges cover image

The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

Goldman Sachs Exchanges

00:00

Breakthrough in Weight Loss Treatments

This chapter discusses the efficacy and safety of newer weight loss drugs, highlighting their ability to achieve 15-20% weight loss. It delves into the potential for wider adoption of anti-obesity drugs and the estimated $100 billion market for these drugs by 2030. The chapter also addresses the cost and insurance coverage of prescription anti-obesity drugs, as well as the long-term effectiveness and challenges of maintaining weight loss.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app